NNextResearch

Krishna Institute of Medical Sciences (KIMS Hospitals) KIMS

Hyderabad-based multi-specialty chain leading in Telangana and Andhra Pradesh, now expanding into Karnataka, Maharashtra and Kerala

Mapped in 1 theme: Hospitals & Healthcare.

From publicly available information

Where Krishna Institute of Medical Sciences (KIMS Hospitals) sits in the supply chain

Krishna Institute of Medical Sciences (KIMS Hospitals) appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.

Revenue and profit

₹ CrFY22FY23FY24FY25FY26
Revenue1,6512,1982,4983,0353,905
Net profit344366336415242

Latest-year revenue ₹3,905 Cr (FY26, company-wide).

Strengths

  • Dominant position and low-cost model in Telangana and Andhra Pradesh
  • Track record of turning around acquired hospitals
  • Large bed pipeline in new states doubles the network over a few years

Risks

  • New-state hospitals (Bengaluru, Nashik, Thane, Kerala) dilute margins in early years
  • Higher share of government-scheme patients in Andhra Pradesh
  • Not to be confused with KIMSHEALTH (Kerala), now part of Aster DM Quality Care

Common questions

What does Krishna Institute of Medical Sciences (KIMS Hospitals) do?

Hyderabad-based multi-specialty chain leading in Telangana and Andhra Pradesh, now expanding into Karnataka, Maharashtra and Kerala.

Where does Krishna Institute of Medical Sciences (KIMS Hospitals) sit in the supply chain?

Krishna Institute of Medical Sciences (KIMS Hospitals) (NSE: KIMS) is mapped in 1 supply-chain layer: Multi-specialty hospital chains (Hospitals & Healthcare).

Who are Krishna Institute of Medical Sciences (KIMS Hospitals)'s peers?

In the Multi-specialty hospital chains layer of Hospitals & Healthcare: Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterprises (Manipal Hospitals), Fortis Healthcare, Global Health (Medanta), Narayana Hrudayalaya (Narayana Health) and 5 more.

What is Krishna Institute of Medical Sciences (KIMS Hospitals)'s market cap and valuation?

As of 6 Nov 2026: market cap ₹30,381 Cr, P/E 150.0x, ROCE 9.5%, ROE 11.3%, dividend yield 0%.